Further, pathway analysis of RNA sequence data did not show overall significant changes in SIRT4 and SIRT5 gene targets between the ATM-wildtype and ATM deficient DLBCL groups (Supplementary Fig. S6A). The gene discussed is SIRT5; the disease is diffuse large B-cell lymphoma.